CSIMarket
 


Stereotaxis Inc   (STXS)
Other Ticker:  
 

Cumulative Stereotaxis Inc 's Working Capital Ratio for Trailing Twelve Months Period

STXS's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

STXS Working Capital Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth -14.83 % 5.31 % 24.18 % 7.76 % 12.36 %
Y / Y Current Assets Growth -27.8 % -16.59 % -13.22 % -15.84 % -13.73 %
Working Capital Ratio for Trailing Twelve Months Period 2.78 2.89 3.06 3.33 3.54
Total Ranking # 736 # # 1346 # 1345 # 1426
Seq. Current Liabilities Growth -7.89 % 0.79 % -0.15 % -8.12 % 13.89 %
Seq. Current Assets Growth -14.49 % -4.9 % -5.41 % -6.15 % -1.2 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Despite year on year decrease in Stereotaxis Inc 's average Current Liabilities to $13 millions, Working Capital Ratio for Trailing Twelve Months Period to 2.78 below company average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 75 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Stereotaxis Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about STXS
Working Capital Ratio STXS in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 76
Sector # 306
S&P 500 # 825


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
3.98 1.98 0.46
(Mar 31 2022)   (Dec 31 2017)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Avita Medical Inc   7.55 
Retractable Technologies inc   7.31 
Brainsway Ltd   7.14 
Aethlon Medical Inc   7.12 
Perspective Therapeutics Inc   7.11 
Vivani Medical Inc   7.08 
Inspiremd Inc   7.08 
Atrion Corporation  7.02 
Inspira Technologies Oxy B h n Ltd   7.02 
Nevro Corp   7.00 
Bone Biologics Corporation  6.92 
Clearpoint Neuro Inc   6.86 
Nephros Inc   6.80 
Icecure Medical Ltd   6.75 
Orthopediatrics Corp  6.65 
Outset Medical Inc   6.60 
Lakeland Industries Inc   6.59 
Profound Medical Corp   6.58 
Lemaitre Vascular Inc   6.54 
Inari Medical Inc   6.49 
Bluejay Diagnostics Inc   6.47 
Glaukos Corp  6.24 
Staar Surgical Company  6.19 
Nexgel Inc   6.18 
Cardiovascular Systems Inc   6.13 
Conformis inc   6.09 
Microbot Medical Inc   6.05 
Anika Therapeutics Inc   6.00 
Predictive Oncology Inc   5.96 
Globus Medical Inc   5.90 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com